Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476565 · ClinicalTrials.gov registry record · NA
Comparison of Endotracheal Intubation Over the Aintree Via the I-gel and Laryngeal Mask Airway Supreme
A NA study of Difficult Intubation, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 2
- Study locations
NCT02476565: Completed NA study of Difficult Intubation, sponsored by Vanderbilt University.
NCT02476565 is a NA study of Difficult Intubation that has completed, run by Vanderbilt University. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02476565, a NA study of Difficult Intubation, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators plan to conduct a randomized trial comparing the efficacy of intubating the tracheal using an Aintree intubation catheter through either the LMA-S or I-gel supraglottic devices
Primary Outcome
This measure of time begins with the handling of the supraglottic device to confirming the appropriate placement of the device by noting the presences of end tidal carbon dioxide.
Conditions Studied
Interventions
- DEVICE LMA-Supreme supraglottic device
- DEVICE I-gel supraglottic device
Study Locations (2)
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- South Texas Veterans HealthCare System - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02476565 record still lists
NCT02476565 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Difficult Intubation appearing as the primary indexed condition, and to 2 interventions - of which LMA-Supreme supraglottic device is the first listed.
NCT02476565 reports a single indexed study location in Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT02476565 about?
NCT02476565 is a clinical study titled "Comparison of Endotracheal Intubation Over the Aintree Via the I-gel and Laryngeal Mask Airway Supreme". The investigators plan to conduct a randomized trial comparing the efficacy of intubating the tracheal using an Aintree intubation catheter through either the LMA-S or I-gel supraglottic devices
What is the current status of trial NCT02476565?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2014-09. Estimated completion is 2016-09.
What conditions does trial NCT02476565 study?
This clinical trial studies the following conditions: Difficult Intubation.
What interventions are being tested in trial NCT02476565?
The interventions under investigation include: LMA-Supreme supraglottic device (DEVICE), I-gel supraglottic device (DEVICE).
Who is sponsoring clinical trial NCT02476565?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02476565 being conducted?
This trial has 2 study locations across Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Difficult Intubation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02476565's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia